Canada markets closed

Biostar Pharmaceuticals, Inc. (BSPM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 03:42PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 316.46k
Enterprise Value 316.46k
Trailing P/E 0.18
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.99
Price/Book (mrq)0.01
Enterprise Value/Revenue 1.00
Enterprise Value/EBITDA 0.06

Trading Information

Stock Price History

Beta (5Y Monthly) -3,298.49
52-Week Change 3-99.00%
S&P500 52-Week Change 323.10%
52 Week High 30.0100
52 Week Low 30.0001
50-Day Moving Average 30.0001
200-Day Moving Average 30.0021

Share Statistics

Avg Vol (3 month) 311
Avg Vol (10 day) 371
Shares Outstanding 52.64M
Implied Shares Outstanding 63.16B
Float 82.21M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Aug 31, 2018) 4170.44k
Short Ratio (Aug 31, 2018) 43
Short % of Float (Aug 31, 2018) 47.74%
Short % of Shares Outstanding (Aug 31, 2018) 46.46%
Shares Short (prior month Jul 31, 2018) 4246.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Feb 05, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sept 30, 2017

Profitability

Profit Margin 294.01%
Operating Margin (ttm)876.46%

Management Effectiveness

Return on Assets (ttm)4.25%
Return on Equity (ttm)2.66%

Income Statement

Revenue (ttm)317.79k
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 3.89M
Net Income Avi to Common (ttm)934.35k
Diluted EPS (ttm)0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)364.97k
Total Cash Per Share (mrq)0.14
Total Debt (mrq)2.43M
Total Debt/Equity (mrq)6.71%
Current Ratio (mrq)0.19
Book Value Per Share (mrq)13.71

Cash Flow Statement

Operating Cash Flow (ttm)8.59M
Levered Free Cash Flow (ttm)7.47M